A take-at-home tablet for multiple sclerosis (MS) is set to be more broadly rolled out on the NHS, potentially benefiting thousands of patients in England. The move will also “significantly free up ...

Based on the results of a pivotal Phase III study, therapy with cladribine tablets has the potential to become a licensed oral disease-modifying medication for relapsing forms of MS. This article ...

Thousands of NHS patients in England with multiple sclerosis (MS) will soon be offered a "take at home" tablet to manage their condition, sparing them hospital visits for injections or infusions.

The post-approval safety profile of cladribine tablets in relapsing MS was updated, with results consistent with development ...

We reviewed the tablets sent to us by reputable companies, such as Amazon, Apple, Microsoft, and OnePlus. They have a track record of producing high quality electronics, and that helps to inform ...